Purdue Loses Case To Stop Generic OxyContin
The bankrupt Purdue Pharma lost its legal effort to use patent laws to block an Indian drugmaker from launching a generic version of OxyContin when a federal judge in Delaware decided...To view the full article, register now.
Already a subscriber? Click here to view full article